Literature DB >> 2068543

A randomized controlled trial to evaluate the effectiveness of homeopathy in rheumatoid arthritis.

L E Andrade1, M B Ferraz, E Atra, A Castro, M S Silva.   

Abstract

Forty-four patients with active Rheumatoid Arthritis were entered into a 6-month double-blind trial comparing homeopathy and placebo. The treatments were generally equally effective in most assessments. Statistically significant improvements were produced, however, in 3 of 5 and 2 of 5 results respectively assessed in homeopathic and placebo treated groups. There was no statistically significant difference between groups. Adverse effects were scarcely and comparably reported in both groups and did not require a change in therapy.

Entities:  

Mesh:

Year:  1991        PMID: 2068543     DOI: 10.3109/03009749109103022

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  4 in total

1.  Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.

Authors:  Sarah Brien; Laurie Lachance; Phil Prescott; Clare McDermott; George Lewith
Journal:  Rheumatology (Oxford)       Date:  2010-11-13       Impact factor: 7.580

2.  Homeopathy satisfaction in Iran.

Authors:  Ahmad Mahmoudian; Gholamhosein Sadri
Journal:  Iran J Nurs Midwifery Res       Date:  2014-09

3.  Report of a Homeopathic Medication Regimen Containing Artemether/Lumefantrine in a Patient With Rheumatoid Arthritis.

Authors:  Suraj Rajasimhan; Adam Schiffenbauer; Mehmet Hocaoğlu; Alice Fike; James D Katz
Journal:  J Clin Rheumatol       Date:  2021-12-01       Impact factor: 3.517

4.  Journeys in the country of the blind: entanglement theory and the effects of blinding on trials of homeopathy and homeopathic provings.

Authors:  Lionel R Milgrom
Journal:  Evid Based Complement Alternat Med       Date:  2006-09-14       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.